Jun 4 |
4DMT Announces Presentations at Clinical Trials at the Summit 2024 Meeting
|
Jun 3 |
4DMT to Participate in Upcoming Investor Conferences
|
May 30 |
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 47ᵗʰ European Cystic Fibrosis Conference
|
May 11 |
We're Interested To See How 4D Molecular Therapeutics (NASDAQ:FDMT) Uses Its Cash Hoard To Grow
|
May 11 |
4D Molecular Therapeutics First Quarter 2024 Earnings: US$0.66 loss per share (vs US$0.88 loss in 1Q 2023)
|
May 10 |
4D Molecular Therapeutics Inc (FDMT) Q1 2024 Earnings: Misses Analyst Net Income Projections
|
May 9 |
4D Molecular Therapeutics reports Q1 results
|
May 9 |
4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
|
May 7 |
4DMT to Participate in Upcoming Investor Conference
|
May 1 |
4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|